Propanc Biopharma (PPCB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.34, +0.15% vs the prior close of $0.34.
- Volume 2.02M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PPCB ends flat (+0.1%) to $0.34. Closed at $0.34, +0.15% vs the prior close of $0.34. Day range $0.32–$0.40, opened at $0.35.
PPCB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PPCB ends flat (+0.1%) to $0.34
- Closed at $0.34, +0.15% vs the prior close of $0.34. Day range $0.32–$0.40, opened at $0.35.
- Volume was 2.02M shares, 0.9x its 50-day average of 2.28M.
- Price is -60.0% vs its 50-day average ($0.85) and -88.4% vs its 200-day average ($2.95).
- 52-week range $0.32–$43.25; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 15, 2026 — PPCB slides 6.6% to $0.34, a 52-week low, 4 down days in a row
- Closed at $0.34, -6.62% vs the prior close of $0.37. Day range $0.33–$0.37, opened at $0.36.
- Volume was 165.10K shares, 0.1x its 50-day average of 2.29M — lighter than usual.
- Price is -61.0% vs its 50-day average ($0.88) and -88.7% vs its 200-day average ($3.02).
- 52-week range $0.33–$47.50; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — PPCB slides 11.3% to $0.37, a 52-week low, 3 down days in a row
- Closed at $0.37, -11.35% vs the prior close of $0.41. Day range $0.37–$0.46, opened at $0.43.
- Volume was 825.70K shares, 0.4x its 50-day average of 2.27M — lighter than usual.
- Price is -59.0% vs its 50-day average ($0.89) and -88.2% vs its 200-day average ($3.09).
- 52-week range $0.37–$47.50; today's close sits at 0% of that range, 99.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — PPCB slides 6.3% to $0.41, a 52-week low
- Closed at $0.41, -6.25% vs the prior close of $0.44. Day range $0.41–$0.44, opened at $0.43.
- Volume was 333.40K shares, 0.1x its 50-day average of 2.27M — lighter than usual.
- Price is -54.4% vs its 50-day average ($0.91) and -86.9% vs its 200-day average ($3.16).
- 52-week range $0.41–$47.50; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 12, 2026 — PPCB slides 9.4% to $0.44, a 52-week low
- Closed at $0.44, -9.41% vs the prior close of $0.49. Day range $0.43–$0.49, opened at $0.49.
- Volume was 195.60K shares, 0.1x its 50-day average of 2.26M — lighter than usual.
- Price is -52.1% vs its 50-day average ($0.92) and -86.4% vs its 200-day average ($3.24).
- 52-week range $0.43–$47.50; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 9, 2026 — PPCB jumps 3.1% to $0.49
- Closed at $0.49, +3.12% vs the prior close of $0.47. Day range $0.46–$0.50, opened at $0.50.
- Volume was 189.30K shares, 0.1x its 50-day average of 2.26M — lighter than usual.
- Price is -47.7% vs its 50-day average ($0.93) and -85.4% vs its 200-day average ($3.32).
- 52-week range $0.46–$48.75; today's close sits at 0% of that range, 99.0% below the 52-week high.
Oct 8, 2026 — PPCB slides 5.6% to $0.47, a 52-week low
- Closed at $0.47, -5.55% vs the prior close of $0.50. Day range $0.46–$0.50, opened at $0.50.
- Volume was 194.70K shares, 0.1x its 50-day average of 2.26M — lighter than usual.
- Price is -49.9% vs its 50-day average ($0.94) and -86.1% vs its 200-day average ($3.40).
- 52-week range $0.46–$49.25; today's close sits at 0% of that range, 99.0% below the 52-week high.
Oct 7, 2026 — PPCB rises 1.5% to $0.50
- Closed at $0.50, +1.51% vs the prior close of $0.49. Day range $0.46–$0.51, opened at $0.50.
- Volume was 878.00K shares, 0.4x its 50-day average of 2.25M — lighter than usual.
- Price is -47.5% vs its 50-day average ($0.95) and -85.7% vs its 200-day average ($3.49).
- 52-week range $0.46–$50.49; today's close sits at 0% of that range, 99.0% below the 52-week high.
Oct 6, 2026 — PPCB dips 1.7% to $0.49, a 52-week low
- Closed at $0.49, -1.74% vs the prior close of $0.50. Day range $0.48–$0.53, opened at $0.48.
- Volume was 187.80K shares, 0.1x its 50-day average of 2.24M — lighter than usual.
- Price is -49.1% vs its 50-day average ($0.96) and -86.3% vs its 200-day average ($3.57).
- 52-week range $0.47–$52.50; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 5, 2026 — PPCB dips 1.5% to $0.50
- Closed at $0.50, -1.48% vs the prior close of $0.51. Day range $0.49–$0.53, opened at $0.51.
- Volume was 90.70K shares, 0.0x its 50-day average of 2.24M — lighter than usual.
- Price is -49.1% vs its 50-day average ($0.98) and -86.4% vs its 200-day average ($3.67).
- 52-week range $0.47–$52.50; today's close sits at 0% of that range, 99.0% below the 52-week high.
- SEC filings that day: S-1.
Oct 2, 2026 — PPCB rises 1.3% to $0.51
- Closed at $0.51, +1.30% vs the prior close of $0.50. Day range $0.50–$0.53, opened at $0.51.
- Volume was 72.00K shares, 0.0x its 50-day average of 2.24M — lighter than usual.
- Price is -49.2% vs its 50-day average ($1.00) and -86.5% vs its 200-day average ($3.75).
- 52-week range $0.47–$52.50; today's close sits at 0% of that range, 99.0% below the 52-week high.
PPCB latest news & SEC filings
Every SEC filing by or about PPCB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Oct 5, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 25, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$18.86M (prior year -$58.92M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$17.62 (prior year -$371.22) (loss narrowed vs Jun 30, 2025)
Aug 21, 2026 · Form DEF 14C — DEF 14C filing
DEF 14C filing
Aug 5, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Jul 27, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 17, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade PPCB
- How much it moves: over the last 20 sessions the average daily move was 4.59% (largest 15.4%). That is a volatile stock.
- Liquidity: about 363.22K shares (≈$124.22K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.34 vs a range of $0.32–$43.25 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on May 18, 2026, 1:2 on Jan 29, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-K Sep 25, 2026; 8-K Jul 14, 2026; 10-Q May 14, 2026.
- Share count: 6.33M shares outstanding (Sep 23, 2026), -50.6% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PPCB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.35 | 0.40 | 0.32 | 0.34 | 2.02M |
| Oct 15, 2026 | 0.36 | 0.37 | 0.33 | 0.34 | 165.10K |
| Oct 14, 2026 | 0.43 | 0.46 | 0.37 | 0.37 | 825.70K |
| Oct 13, 2026 | 0.43 | 0.44 | 0.41 | 0.41 | 333.40K |
| Oct 12, 2026 | 0.49 | 0.49 | 0.43 | 0.44 | 195.60K |
| Oct 9, 2026 | 0.50 | 0.50 | 0.46 | 0.49 | 189.30K |
| Oct 8, 2026 | 0.50 | 0.50 | 0.46 | 0.47 | 194.70K |
| Oct 7, 2026 | 0.50 | 0.51 | 0.46 | 0.50 | 878.00K |
| Oct 6, 2026 | 0.48 | 0.53 | 0.48 | 0.49 | 187.80K |
| Oct 5, 2026 | 0.51 | 0.53 | 0.49 | 0.50 | 90.70K |
| Oct 2, 2026 | 0.51 | 0.53 | 0.50 | 0.51 | 72.00K |
| Oct 1, 2026 | 0.49 | 0.52 | 0.49 | 0.50 | 82.90K |
| Sep 30, 2026 | 0.52 | 0.52 | 0.47 | 0.49 | 131.40K |
| Sep 29, 2026 | 0.51 | 0.55 | 0.50 | 0.51 | 143.90K |
| Sep 28, 2026 | 0.62 | 0.62 | 0.52 | 0.53 | 421.60K |
| Sep 25, 2026 | 0.59 | 0.67 | 0.59 | 0.63 | 384.20K |
| Sep 24, 2026 | 0.63 | 0.67 | 0.56 | 0.60 | 192.30K |
| Sep 23, 2026 | 0.64 | 0.65 | 0.60 | 0.63 | 192.90K |
| Sep 22, 2026 | 0.65 | 0.68 | 0.64 | 0.65 | 424.60K |
| Sep 21, 2026 | 0.61 | 0.65 | 0.60 | 0.63 | 142.30K |
About Propanc Biopharma
Propanc Biopharma (PPCB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBERWELL, VICTORIA, Australia. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1517681.
PPCB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PPCB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-18.86M | -17.62 | $-5.68M |
| Jun 30, 2025 | — | $-58.92M | -371.22 | $-405.17K |
| Jun 30, 2024 | — | $-1.82M | -1,420.53 | $-935.12K |
| Jun 30, 2023 | — | $-2.66M | -1.80 | $-1.11M |
| Jun 30, 2022 | — | $-2.66M | -49.23 | $-1.44M |
Latest balance sheet: total assets $12.78M, total liabilities $3.38M, cash $93.24K (as of Jun 30, 2026).
PPCB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PPCB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.